Filing Overview
This Form 8-K was filed by Tivic Health Systems, Inc. on March 25, 2024, under Items 2.02 and 7.01. It reports that the company issued a press release concerning financial results for the fiscal year ended December 31, 2023. The request metadata identifies Valion Bio, Inc., but the filing itself identifies the registrant as Tivic Health Systems, Inc. (Nasdaq: TIVC).
Financial Results and Liquidity
The filing incorporates by reference Exhibit 99.1, a March 25, 2024 press release regarding fiscal 2023 results. The provided filing text does not include the press release contents and therefore does not provide clear values for revenue, profit or loss, cash flow, margins, debt, cash balances, liquidity, or other financial metrics.
Changes Versus Prior Period
The filing text does not provide a clear comparison of fiscal 2023 results with the prior comparable period.
Outlook, Risks, and Other Matters
- The filing contains forward-looking statements involving substantial risks and uncertainties.
- Risks cited generally include factors that could cause actual operating or financial results to differ materially from management’s expectations, including risks described in the filing and other SEC filings.
- No specific guidance, forecast, contingency, unusual item, financing transaction, or material operational development is described in the provided text.
- The Item 7.01 information and Exhibit 99.1 are furnished, not filed, for purposes of Section 18 of the Exchange Act and are not incorporated by reference into other filings except by specific reference.
Investor Verification Items
- Review Exhibit 99.1 for the actual fiscal 2023 financial results and year-over-year comparisons.
- Verify cash, liquidity, operating cash burn, debt obligations, and any going-concern or financing disclosures in the complete earnings release and related filings.
- Confirm the registrant’s identity and ticker, because the provided request metadata names Valion Bio, Inc., while the filing identifies Tivic Health Systems, Inc. and TIVC.
- Assess the specific assumptions and risk factors underlying any forward-looking statements.